Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of MenACWY Conjugate Vaccine Antibodies in Children
NCT01148017Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2010
- Primary completion
- Apr 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen in meningococcal meningitis, sponsored by Novartis. Started Jul 2010; status: completed.
02
Drugs
neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT01148017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01148017.